Black Diamond Therapeutics, Inc. (BDTX) Tops Q2 EPS by 2c

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q2 EPS of ($0.52), $0.02 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c